What was Mera Pharmaceuticals’s price range in the past 12 months?
Mera Pharmaceuticals lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Mera Pharmaceuticals’s market cap?
Mera Pharmaceuticals’s market cap is $537.
When is Mera Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Mera Pharmaceuticals overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Mera Pharmaceuticals pay dividends?
Mera Pharmaceuticals does not currently pay dividends.
What is Mera Pharmaceuticals’s EPS estimate?
Mera Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mera Pharmaceuticals have?
Mera Pharmaceuticals has 536,654,050 shares outstanding.
Which hedge fund is a major shareholder of Mera Pharmaceuticals?
Currently, no hedge funds are holding shares in MRPI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mera Pharmaceuticals
Mera Pharmaceuticals, Inc. focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology. The company is also involved in the development of sea salt; and operation of family entertainment center focused on promoting health and wellness through the Villari’s system of martial arts. In addition, it provides food production and delivery services. Mera Pharmaceuticals, Inc. was founded in 1983 and is based in Las Vegas, Nevada.